Wellington Management Group LLP Immuno Gen, Inc. Transaction History

Wellington Management Group LLP

$548 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$12.46 - $29.95 $24.4 Million - $58.5 Million	1,954,413 New	1,954,413 $57.9 Million
Q3 2023 Nov 14, 2023	BUY	$14.09 - $19.87 $49.4 Million - $69.7 Million	3,506,098 Added 35.95%	13,258,997 $210 Million
Q2 2023 Aug 14, 2023	SELL	$3.75 - $20.05 $419,572 - $2.24 Million	-111,886 Reduced 1.13%	9,752,899 $184 Million
Q1 2023 May 12, 2023	BUY	$3.67 - $4.92 $2.34 Million - $3.14 Million	638,077 Added 6.92%	9,864,785 $37.9 Million
Q4 2022 Feb 13, 2023	SELL	$4.55 - $6.31 $3.55 Million - $4.93 Million	-780,797 Reduced 7.8%	9,226,708 $45.8 Million
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $3.18 Million - $4.59 Million	-709,580 Reduced 6.62%	10,007,505 $47.8 Million
Q2 2022 Aug 15, 2022	SELL	$3.15 - $5.76 $7.39 Million - $13.5 Million	-2,346,399 Reduced 17.96%	10,717,085 $48.2 Million
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $3.57 Million - $6.28 Million	-839,014 Reduced 6.03%	13,063,484 $62.2 Million
Q4 2021 Feb 11, 2022	SELL	$4.75 - $7.5 $786,647 - $1.24 Million	-165,610 Reduced 1.18%	13,902,498 $103 Million
Q3 2021 Nov 15, 2021	SELL	$5.02 - $6.59 $2.63 Million - $3.46 Million	-524,462 Reduced 3.59%	14,068,108 $79.8 Million
Q2 2021 Aug 16, 2021	SELL	$5.79 - $8.6 $25.5 Million - $37.9 Million	-4,410,910 Reduced 23.21%	14,592,570 $96.2 Million
Q1 2021 May 17, 2021	SELL	$6.5 - $10.53 $20 Million - $32.4 Million	-3,080,623 Reduced 13.95%	19,003,480 $154 Million
Q4 2020 Feb 12, 2021	SELL	$3.7 - $7.66 $3.69 Million - $7.63 Million	-996,025 Reduced 4.32%	22,084,103 $142 Million
Q3 2020 Nov 16, 2020	SELL	$3.45 - $4.89 $798,709 - $1.13 Million	-231,510 Reduced 0.99%	23,080,128 $83.1 Million
Q2 2020 Aug 14, 2020	BUY	$3.32 - $5.34 $13.8 Million - $22.2 Million	4,160,256 Added 21.72%	23,311,638 $107 Million
Q1 2020 May 14, 2020	BUY	$2.12 - $6.8 $40.5 Million - $130 Million	19,109,675 Added 45818.87%	19,151,382 $65.3 Million
Q4 2019 Feb 11, 2020	BUY	$2.25 - $5.8 $93,840 - $241,900	41,707 New	41,707 $213,000

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.

Account